以介白素二號及干擾素的用於治療具高度復發危險性,並且已經接受自體骨髓移植或周邊血液造血母細胞移植的血液惡性疾病
Treatment with interleukin-2 (IL-2) and interferon (INFalpha 2b) after autologous bone marrow or peripheral blood stem cell transplantation in onco-hematological malignancies with a high risk of relapse
出處:
Bone Marrow Transplantation,(1999) 23, 169-172作者:
P Vivancos, A Granena Jr, J Sarra and A Granena譯者:梁欽琦